GT Biopharma Inc expected to post a loss of $2.70 a share - Earnings Preview

GT Biopharma

26/03/2024 11:02

* GT Biopharma Inc  GTBP.OQ   GTBP.O  is expected to show no
change in quarterly revenue when it reports  results on March 28
(estimated) for the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for GT Biopharma Inc is for
a loss
of $2.70 per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for GT
Biopharma Inc
is $150.00​, above​ its last closing price of $4.41. ​​​

This summary was machine generated March 26 at 11:02 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)